Free Trial

Focus Partners Wealth Sells 1,488 Shares of Cigna Group $CI

Cigna Group logo with Medical background

Key Points

  • Focus Partners Wealth has decreased its stake in Cigna Group by 6.3%, now holding 22,320 shares valued at approximately $7.34 million.
  • A number of large investors are increasing their stakes in Cigna Group, with Two Sigma Investments LP boosting its position by 32.6% during the fourth quarter.
  • Cigna Group's recent quarterly earnings report showed an EPS of $7.20, surpassing expectations and reflecting an 11.0% year-over-year revenue growth.
  • Interested in Cigna Group? Here are five stocks we like better.

Focus Partners Wealth reduced its stake in Cigna Group (NYSE:CI - Free Report) by 6.3% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 22,320 shares of the health services provider's stock after selling 1,488 shares during the period. Focus Partners Wealth's holdings in Cigna Group were worth $7,344,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds also recently made changes to their positions in the company. Flaharty Asset Management LLC bought a new position in Cigna Group in the 1st quarter valued at approximately $28,000. 1248 Management LLC bought a new position in Cigna Group in the 1st quarter valued at approximately $29,000. Activest Wealth Management raised its holdings in Cigna Group by 360.0% in the 1st quarter. Activest Wealth Management now owns 92 shares of the health services provider's stock valued at $30,000 after buying an additional 72 shares during the last quarter. Putney Financial Group LLC bought a new position in Cigna Group in the 4th quarter valued at approximately $36,000. Finally, Saudi Central Bank bought a new position in Cigna Group in the 1st quarter valued at approximately $36,000. 86.99% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Cigna Group

In other news, insider Nicole S. Jones sold 28,526 shares of the company's stock in a transaction dated Friday, August 15th. The stock was sold at an average price of $300.00, for a total transaction of $8,557,800.00. Following the sale, the insider directly owned 25,648 shares in the company, valued at $7,694,400. This represents a 52.66% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. 0.70% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on the stock. Robert W. Baird set a $372.00 price objective on shares of Cigna Group in a report on Thursday, August 14th. Wall Street Zen upgraded shares of Cigna Group from a "hold" rating to a "buy" rating in a report on Saturday, September 13th. Wells Fargo & Company lowered their price target on shares of Cigna Group from $341.00 to $340.00 and set an "equal weight" rating for the company in a report on Thursday, August 14th. Truist Financial set a $375.00 price target on shares of Cigna Group in a report on Tuesday, September 2nd. Finally, Deutsche Bank Aktiengesellschaft set a $415.00 price target on shares of Cigna Group and gave the stock a "buy" rating in a report on Tuesday, August 5th. Two equities research analysts have rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and two have issued a Hold rating to the company. According to MarketBeat, the stock currently has an average rating of "Buy" and a consensus price target of $371.81.

Read Our Latest Analysis on CI

Cigna Group Trading Down 0.9%

Shares of CI stock traded down $2.69 during trading hours on Thursday, hitting $293.90. 1,179,541 shares of the company were exchanged, compared to its average volume of 1,319,745. The firm has a market cap of $78.45 billion, a P/E ratio of 16.04, a P/E/G ratio of 0.87 and a beta of 0.48. Cigna Group has a fifty-two week low of $256.89 and a fifty-two week high of $358.91. The company has a debt-to-equity ratio of 0.65, a quick ratio of 0.71 and a current ratio of 0.71. The company has a 50 day simple moving average of $294.24 and a two-hundred day simple moving average of $311.67.

Cigna Group (NYSE:CI - Get Free Report) last announced its quarterly earnings data on Thursday, July 31st. The health services provider reported $7.20 EPS for the quarter, topping the consensus estimate of $7.15 by $0.05. The company had revenue of $67.13 billion during the quarter, compared to the consensus estimate of $62.61 billion. Cigna Group had a net margin of 1.92% and a return on equity of 18.80%. The company's quarterly revenue was up 11.0% on a year-over-year basis. During the same quarter last year, the firm posted $6.72 EPS. Cigna Group has set its FY 2025 guidance at 29.600- EPS. Equities analysts anticipate that Cigna Group will post 29.77 EPS for the current year.

Cigna Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, September 18th. Stockholders of record on Thursday, September 4th will be given a dividend of $1.51 per share. The ex-dividend date is Thursday, September 4th. This represents a $6.04 annualized dividend and a dividend yield of 2.1%. Cigna Group's dividend payout ratio is currently 32.97%.

Cigna Group Company Profile

(Free Report)

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.

Further Reading

Institutional Ownership by Quarter for Cigna Group (NYSE:CI)

Should You Invest $1,000 in Cigna Group Right Now?

Before you consider Cigna Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cigna Group wasn't on the list.

While Cigna Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.